- Company being the first one to launch Remdesivir and the whole portfolio for covid 19
- Company is no.2 in lung leadership. Will try to unlock the complex generics in US.
- Growing faster than the average market growth.
Very important that obvious failures with Track and Trace and self-isolation (study late last year said 18% of people complying https://t.co/dhJUZ7Pm0l) are not painted as an enforcement issue. Plainly not. Would just pass buck to police who have almost no capacity to enforce https://t.co/Eb4Kl5Ze0E
— Adam Wagner (@AdamWagner1) January 25, 2021